Key facts
- Notable investors include Macau University of Science and Technology Foundation.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Joint Innovation
- ·The full record, as it builds
Funding rounds
No funding rounds for Joint Innovation are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Joint Innovation
Developer of cell technology solutions designed for advancing pharmaceutical and healthcare innovation. The company provides research and development, as well as quality control systems for cell and gene therapy products, enabling the healthcare industry with cutting-edge solutions for drug development and standardization.
- Sector
- Healthcare
- HQ
- Tianjin, China
- Founded
- 2020
- Website
- tjjibio.com/
- Ownership
- Privately Held (backing)
Joint Innovation doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Joint Innovation shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Joint Innovation in its N-PORT filings yet. We sweep new filings monthly.